The final version of the 2022 OPS procedure coding classification released in Germany


Nov 2021

In late October 2021, the BfArM (Federal Institute for Drugs and Medical Devices) has published the final version of the 2022 OPS procedure coding classification. The OPS, together with the ICD-10-GM (International Statistical Classification of Diseases and Related Health Problems, 10th revision, German Modification), forms the basis for the reimbursement systems in outpatient and inpatient care.

Two hundred twenty-three (223) proposals submitted by representatives of the professional societies and associations health insurance companies and healthcare institutions were incorporated in the OPS 2022.

Numerous content updates and new procedure codes inclusion concern the chapters 5 "Operations" and 8 "Non-operative therapeutic measures". Also, changes were made in chapters 1 “Diagnostic measures” and 3 “Diagnostic imaging”. Some examples of newly introduced codes per technology group are provided below:


  • 5-35a.06 Implantation of an aortic valve replacement: Transapical;
  • 5-35a.10 Implantation of a pulmonary valve replacement: Endovascular;
  • 5-35a.33 Implantation of a mitral valve replacement: Transapical;
  • 5-377.h1 Use of pacemakers with additional measurement or special stimulation function: With quadripolar stimulation function;
  • 5-377.n0 System for stimulation of the conduction system: With 2 electrodes;
  • 5-379.e Endovascular implantation of a stent prosthesis with valve function in the right atrium.


  • 1-999.40 Type of cystoscope: Rigid cystoscope;
  • 1-999.42 Type of cystoscope: Flexible reusable cystoscope;
  • 5-339.b Use of an ultra-thin tracheobronchoscope.


  • 5-46b.0 Additional information on operations on the intestine: Endoscopy using the push-and-pull-back technique;
  • 5-46b.1 Additional information on operations on the intestine: Motorized spiral endoscopy;

Interventional radiology

  • 5-339.25 Destruction of diseased lung tissue: Using radiofrequency ablation, percutaneous;
  • 5-501.a** Local excision and destruction of diseased tissue of the liver (atypical liver resection): Destruction, local, using microwave ablation.

In-vitro diagnostics

  • 1-991.2 Molecular genetic identification of disease-specific markers for the determination of the residual tumor burden (Minimal Residual Disease [MRD]);
  • 1-991.3 Disease-specific molecular genetic quantification of the residual tumor burden [MRD-monitoring];
  • 1-997.18 Analysis of coding sequence including associated regulatory sequences, liquid biopsy: More than 40 kilobases.


  • 5-209.10 Operation on the auditory tube: Balloon dilation;
  • 5-310.20 Thyroplasty: With autogenous tissue;

The 2022 version of the OPS classification can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.

The latest related news


Jun 2023

In the period of April-May 2023, the Galician Agency for Health Technology Assessment (AVALIA-T) initiated the five health technology assessments referred to IVD, nephrology and urology, obstetrics and gynecology, pulmonary and airways as well as surgical procedures technology groups. The assessments on stereotactic virtual navigation system for percutaneous puncture as well as tumor ablation and invasive telemonitoring of pulmonary pressure in patients with heart failure were released.

Read more


Jun 2023

In May 2023, the National Institute for Health and Care Excellence (NICE) published one new Interventional Procedure Guidance (intramuscular diaphragm stimulation for ventilator-dependent chronic respiratory failure from high spinal cord injuries), two new Diagnostic Guidance (MRI fusion biopsy systems for diagnosing prostate cancer, automated ankle-brachial pressure index measurement devices to detect peripheral arterial disease), and three new Health Technology Evaluations (Digitally enabled therapies for adults with anxiety disorders / with depression, and point-of-care tests for urinary tract infections). Also, four clinical guidelines were updated.

Read more


Jun 2023

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in May 2023. Twenty-one recommendations were published in relation to the registration, modification of registration conditions, and renewal of registration for devices in the List of reimbursable products and services (LPPR). Opinions concern cardiovascular and peripheral vascular, endocrine, ENT, gastrointestinal, and orthopedic devices, as well as medical aids.

Read more


Jun 2023

On May 15, 2023, the Innovation Committee at the Federal Joint Committee (G-BA) published the decisions, recommending the transfer to standard care for another three completed projects. The projects relate to controlling drug prescriptions in outpatient settings, evaluating the effectiveness of outpatient extensive stuttering therapy in primary school children, and the efficacy of cross-sectoral care models in psychiatry.

Read more


Jun 2023

On May 23, 2023, the Ministry of Health and Prevention published an Order in the Official Journal of the French Republic setting the tariffs for the medical telemonitoring activities covered by social health insurance in the context of the new framework. The tariffs will differ whether they bring an organizational or clinical (improvement in quality of life, morbidity, or mortality) benefit.

Read more